|
US3926891A
(en)
|
1974-03-13 |
1975-12-16 |
Dow Chemical Co |
Method for making a crosslinkable aqueous solution which is useful to form soft, water-swellable polyacrylate articles
|
|
US3935099A
(en)
|
1974-04-03 |
1976-01-27 |
The United States Of America As Represented By The Secretary Of Agriculture |
Method of reducing water content of emulsions, suspensions, and dispersions with highly absorbent starch-containing polymeric compositions
|
|
US3997484A
(en)
|
1974-04-03 |
1976-12-14 |
The United States Of America As Represented By The Secretary Of Agriculture |
Highly-absorbent starch-containing polymeric compositions
|
|
US4090013A
(en)
|
1975-03-07 |
1978-05-16 |
National Starch And Chemical Corp. |
Absorbent composition of matter
|
|
JPS51125468A
(en)
|
1975-03-27 |
1976-11-01 |
Sanyo Chem Ind Ltd |
Method of preparing resins of high water absorbency
|
|
JPS5346389A
(en)
|
1976-10-07 |
1978-04-25 |
Kao Corp |
Preparation of self-crosslinking polymer of acrylic alkali metal salt
|
|
US4190562A
(en)
|
1977-04-04 |
1980-02-26 |
The B. F. Goodrich Company |
Improved water absorbent copolymers of copolymerizable carboxylic acids and acrylic or methacrylic esters
|
|
US4470975A
(en)
|
1977-10-21 |
1984-09-11 |
The Johns Hopkins University |
Method and composition for the elimination of water from an animal body
|
|
US4286082A
(en)
|
1979-04-06 |
1981-08-25 |
Nippon Shokubai Kagaku Kogyo & Co., Ltd. |
Absorbent resin composition and process for producing same
|
|
JPS6025045B2
(ja)
|
1980-03-19 |
1985-06-15 |
製鉄化学工業株式会社 |
塩水吸収能のすぐれたアクリル酸重合体の製造方法
|
|
JPS57158209A
(en)
|
1981-03-25 |
1982-09-30 |
Kao Corp |
Production of bead-form highly water-absorbing polymer
|
|
JPS5832607A
(ja)
|
1981-08-20 |
1983-02-25 |
Kao Corp |
吸水性に優れた吸水材料の製造法
|
|
US4985518A
(en)
|
1981-10-26 |
1991-01-15 |
American Colloid Company |
Process for preparing water-absorbing resins
|
|
JPS6187702A
(ja)
|
1984-10-05 |
1986-05-06 |
Seitetsu Kagaku Co Ltd |
吸水性樹脂の製造方法
|
|
US4708997A
(en)
|
1985-07-22 |
1987-11-24 |
The Dow Chemical Company |
Suspending agent for the suspension polymerization of water-soluble monomers
|
|
US4806532A
(en)
|
1985-10-08 |
1989-02-21 |
Mayo Foundation For Medical Education And Research |
Inhibition of epithelial phosphate transport
|
|
DE3544770A1
(de)
|
1985-12-18 |
1987-06-19 |
Stockhausen Chem Fab Gmbh |
Verfahren und vorrichtung zum kontinuierlichen herstellen von polymerisaten und copolymerisaten der acrylsaeure und/oder methacrylsaeure
|
|
US4766004A
(en)
|
1986-12-19 |
1988-08-23 |
Warner-Lambert Company |
Crunchy, highly palatable, bulk-increasing, dietary fiber supplement composition
|
|
IT1217123B
(it)
|
1987-02-05 |
1990-03-14 |
Rotta Research Lab |
Derivati otticamente attivi dell acido 5 pentilammino 5 oxo pentanoico r ad attivita antagonista della colecistochinina e procedimento per la loro preparazione
|
|
US4999200A
(en)
|
1987-12-09 |
1991-03-12 |
Marion Laboratories |
Psyllium tablet composition, method of manufacture and method of use
|
|
US5149541A
(en)
|
1988-10-03 |
1992-09-22 |
The Procter & Gamble Company |
Psyllium-containing produces with a distribution of particle size
|
|
US5145906A
(en)
|
1989-09-28 |
1992-09-08 |
Hoechst Celanese Corporation |
Super-absorbent polymer having improved absorbency properties
|
|
US5126150A
(en)
|
1990-10-01 |
1992-06-30 |
The Procter & Gamble Company |
Compositions containing psyllium
|
|
HUT64023A
(en)
|
1991-03-22 |
1993-11-29 |
Sandoz Ag |
Process for producing aminoguanidine derivatives and pharmaceutical compositions comprising such compounds
|
|
FR2674849B1
(fr)
|
1991-04-02 |
1994-12-23 |
Logeais Labor Jacques |
Nouveaux derives de n-cyclohexyl benzamides ou thiobenzamides, leurs preparations et leurs applications en therapeutique.
|
|
US5140102A
(en)
|
1991-09-23 |
1992-08-18 |
Monsanto Company |
Pentadecapeptide, guanylin, which stimulates intestinal guanylate cyclase
|
|
SG50624A1
(en)
|
1991-12-30 |
1998-07-20 |
Neurex Corp |
Methods of producing analgesia and enhancing opiate analgesia
|
|
US5824645A
(en)
|
1991-12-30 |
1998-10-20 |
Neurex Corporation |
Method of treating inflammation
|
|
US5969097A
(en)
|
1992-06-23 |
1999-10-19 |
G. D. Searle & Co. |
Human guanylin
|
|
DE59403818D1
(de)
|
1993-02-20 |
1997-10-02 |
Hoechst Ag |
Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, als Inhibitoren des zellulären Na+/H+-Austauschs oder als Diagnostikum sowie sie enthaltendes Medikament
|
|
US5629377A
(en)
|
1993-03-10 |
1997-05-13 |
The Dow Chemical Company |
Water absorbent resin particles of crosslinked carboxyl containing polymers and method of preparation
|
|
IL109570A0
(en)
|
1993-05-17 |
1994-08-26 |
Fujisawa Pharmaceutical Co |
Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
|
|
US5489670A
(en)
|
1993-10-29 |
1996-02-06 |
G. D. Searle & Co. |
Human uroguanylin
|
|
US7357946B2
(en)
|
1994-04-15 |
2008-04-15 |
Adamoli Jr James R |
Uses for cellulose-containing aggregates
|
|
US5610145A
(en)
|
1994-04-15 |
1997-03-11 |
Warner-Lambert Company |
Tachykinin antagonists
|
|
US5650222A
(en)
|
1995-01-10 |
1997-07-22 |
The Procter & Gamble Company |
Absorbent foam materials for aqueous fluids made from high internal phase emulsions having very high water-to-oil ratios
|
|
DE19518796A1
(de)
|
1995-05-22 |
1996-11-28 |
Hoechst Ag |
Fluorphenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
|
US5795864A
(en)
|
1995-06-27 |
1998-08-18 |
Neurex Corporation |
Stable omega conopetide formulations
|
|
ES2283671T3
(es)
|
1995-06-27 |
2007-11-01 |
EISAI R&D MANAGEMENT CO., LTD. |
Composiciones y formulaciones para producir analgesia y para inhibir la progresion de transtornos de dolor neuropatico.
|
|
US6054429A
(en)
|
1996-03-08 |
2000-04-25 |
Elan Pharmaceuticals, Inc. |
Epidural method of producing analgesia
|
|
US5550167A
(en)
|
1995-08-30 |
1996-08-27 |
The Procter & Gamble Company |
Absorbent foams made from high internal phase emulsions useful for acquiring aqueous fluids
|
|
GB9524104D0
(en)
|
1995-11-24 |
1996-01-24 |
Smithkline Beecham Spa |
Novel compounds
|
|
CN1207730A
(zh)
|
1995-11-24 |
1999-02-10 |
史密丝克莱恩比彻姆股份公司 |
喹啉衍生物
|
|
DE19548812A1
(de)
|
1995-12-27 |
1997-07-03 |
Hoechst Ag |
Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikaments zur Atemstimulation
|
|
EP0837055A1
(en)
|
1996-07-30 |
1998-04-22 |
Hoechst Aktiengesellschaft |
Substituted Indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them
|
|
DE19633966A1
(de)
|
1996-08-22 |
1998-02-26 |
Hoechst Ag |
Phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
|
WO1998011090A2
(en)
|
1996-09-16 |
1998-03-19 |
Warner-Lambert Company |
3-alkyl-3-phenyl-piperidines
|
|
ATE386531T1
(de)
|
1997-02-28 |
2008-03-15 |
Nycomed Gmbh |
Synergistische kombination von pde-hemmern und adenylatcyclase-agonisten bzw. guanylcyclyse- agonisten
|
|
NZ329807A
(en)
|
1997-04-23 |
2000-07-28 |
Pfizer |
NK-1 receptor antagonists and P receptor antagonists 2-Diarylmethyl-3-amino-1-azabicyclo[2.2.2]octane derivatives and amino substituted N-containing rings as agents for treating irritable bowel syndrome
|
|
KR100219918B1
(ko)
|
1997-07-03 |
1999-09-01 |
김윤 |
대장선택적 약물전달용 조성물
|
|
US20010006972A1
(en)
|
1998-04-21 |
2001-07-05 |
Stephen A. Williams |
Nk-1 receptor antagonists for the treatment of symptoms of irritable bowel syndrome
|
|
KR20000011247A
(ko)
|
1998-07-23 |
2000-02-25 |
김윤 |
다당류를이용한대장선택성약물전달조성물및약학제제
|
|
DE19849722A1
(de)
|
1998-10-28 |
2000-05-04 |
Aventis Pharma Gmbh |
Substituierte Phenyl-alkenoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
|
HK1041703A1
(zh)
|
1999-01-21 |
2002-07-19 |
Board Of Regents The University Of Texas System |
肠道顶膜钠/磷酸盐共同传送的抑制剂
|
|
FR2789493B1
(fr)
|
1999-02-09 |
2001-03-09 |
Gemplus Card Int |
Procede de detection d'objets portables et systeme de mise en oeuvre
|
|
US6624150B2
(en)
|
1999-02-26 |
2003-09-23 |
Inspire Pharmaceuticals, Inc. |
Method of treating gastrointestinal tract disease with purinergic receptor agonists
|
|
US6287609B1
(en)
|
1999-06-09 |
2001-09-11 |
Wisconsin Alumni Research Foundation |
Unfermented gel fraction from psyllium seed husks
|
|
MXPA02000684A
(es)
|
1999-07-19 |
2003-07-21 |
Univ North Carolina |
Conjugados de bloqueadores del canal de sodio y metodos de uso de los mismos.
|
|
AR030911A1
(es)
|
1999-07-20 |
2003-09-03 |
Smithkline Beecham Corp |
Uso de n-aril-2-sulfonamidobenzamidas para la manufactura de un medicamento para el tratamiento de la insuficiencia renal cronica y composiciones farmaceuticas
|
|
US6107356A
(en)
|
1999-08-23 |
2000-08-22 |
The Procter & Gamble Company |
High suction polymeric foam materials
|
|
DE19941764A1
(de)
|
1999-09-02 |
2001-03-15 |
Aventis Pharma Gmbh |
Substituierte Acylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikamente oder Diagnostika sowie sie enthaltende Medikamente
|
|
SE9903291D0
(sv)
|
1999-09-15 |
1999-09-15 |
Astra Ab |
New process
|
|
DE19945302A1
(de)
|
1999-09-22 |
2001-03-29 |
Merck Patent Gmbh |
Biphenylderivate als NHE-3-Inhibitoren
|
|
US6887870B1
(en)
|
1999-10-12 |
2005-05-03 |
Bristol-Myers Squibb Company |
Heterocyclic sodium/proton exchange inhibitors and method
|
|
DK1225897T3
(da)
|
1999-11-01 |
2005-01-10 |
John Rhodes |
Sammensætning til behandling af obstipation og colon irritabile
|
|
AUPQ514600A0
(en)
|
2000-01-18 |
2000-02-10 |
James Cook University |
Brain injury treatment
|
|
WO2001064212A1
(en)
|
2000-03-01 |
2001-09-07 |
University College London |
Modulators of the endocannabinoid uptake and of the vallinoid receptors
|
|
DE10015248A1
(de)
|
2000-03-28 |
2001-10-04 |
Merck Patent Gmbh |
Bisamidino-Verbindungen als NHE-3 Inhibitoren
|
|
DE10019062A1
(de)
|
2000-04-18 |
2001-10-25 |
Merck Patent Gmbh |
2-Guanidino-4-aryl-chinazoline als NHE-3 Inhibitoren
|
|
AU2001259354A1
(en)
|
2000-05-02 |
2001-11-12 |
Smith Kline Beecham Corporation |
Phosphate transport inhibitors
|
|
CA2408667A1
(en)
*
|
2000-05-12 |
2001-11-22 |
Joseph Weinstock |
Phosphate transport inhibitors
|
|
DE10043667A1
(de)
|
2000-09-05 |
2002-03-14 |
Merck Patent Gmbh |
2-Guanidino-4-aryl-chinazoline
|
|
US6414016B1
(en)
|
2000-09-05 |
2002-07-02 |
Sucampo, A.G. |
Anti-constipation composition
|
|
DE10046993A1
(de)
|
2000-09-22 |
2002-04-11 |
Aventis Pharma Gmbh |
Substituierte Zimtsäureguanidide, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltendes Medikament
|
|
WO2002028353A2
(en)
|
2000-10-05 |
2002-04-11 |
Smithkline Beecham Corporation |
Phosphate transport inhibitors
|
|
DE60132256T2
(de)
|
2000-11-20 |
2008-12-24 |
Sorbent Therapeutics, Inc., Vernon Hills |
Wasserabsorbierende polymere und deren verwendung
|
|
DE10063294A1
(de)
|
2000-12-19 |
2002-07-04 |
Aventis Pharma Gmbh |
Substituierte Heterocyclo-Norbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
|
CA2905585C
(en)
|
2001-03-29 |
2020-02-18 |
Synergy Pharmaceuticals, Inc. |
Guanylate cyclase receptor agonists for the treatment and/or prevention of cancer or polyps
|
|
US6736705B2
(en)
|
2001-04-27 |
2004-05-18 |
Hitachi Global Storage Technologies |
Polishing process for glass or ceramic disks used in disk drive data storage devices
|
|
US20030216449A1
(en)
*
|
2001-05-11 |
2003-11-20 |
Joseph Weinstock |
Phosphate transport inhibitors
|
|
MY134211A
(en)
|
2001-05-18 |
2007-11-30 |
Smithkline Beecham Corp |
Novel use
|
|
JP2007131532A
(ja)
|
2001-09-28 |
2007-05-31 |
Kirin Brewery Co Ltd |
生体内リン輸送を阻害する化合物およびそれを含んでなる医薬
|
|
FR2830451B1
(fr)
|
2001-10-09 |
2004-04-30 |
Inst Nat Sante Rech Med |
Utilisation de peptides analogues de la thymuline(pat)pour la fabrication de medicaments contre la douleur
|
|
WO2003048129A1
(de)
|
2001-12-05 |
2003-06-12 |
Aventis Pharma Deutschland Gmbh |
Substituierte 4-phenyltetrahydroisochinoline, verfahren zu ihrer herstellung, ihre verwendung als medikament, sowie sie enthaltendes medikament
|
|
AU2002354410A1
(en)
|
2001-12-05 |
2003-06-17 |
Japan Tobacco Inc. |
Triazole compound and medicinal use thereof
|
|
US6911453B2
(en)
|
2001-12-05 |
2005-06-28 |
Aventis Pharma Deutschland Gmbh |
Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them
|
|
DE10161767A1
(de)
|
2001-12-15 |
2003-06-26 |
Merck Patent Gmbh |
2-Guanidino-4-heterocyclyl-chinazoline
|
|
EP1321142A1
(en)
|
2001-12-21 |
2003-06-25 |
Novartis AG |
Solid pharmaceutical composition for oral administration of Tegaserod
|
|
US6703405B2
(en)
|
2001-12-22 |
2004-03-09 |
Aventis Pharma Deutschland Gmbh |
Substituted 4-phenyltetrahydroisoquinolinium salts, process for their preparation, their use as a medicament, and medicament containing them
|
|
DE10163992A1
(de)
|
2001-12-24 |
2003-07-03 |
Merck Patent Gmbh |
4-Aryl-chinazoline
|
|
US7119120B2
(en)
|
2001-12-26 |
2006-10-10 |
Genzyme Corporation |
Phosphate transport inhibitors
|
|
AU2003218270A1
(en)
|
2002-03-19 |
2003-10-08 |
Genzyme Corporation |
Phosphate transport inhibitors
|
|
WO2003097051A2
(en)
|
2002-05-17 |
2003-11-27 |
Merck Patent Gmbh |
Use of compounds that are effective as selective opiate receptor modulators
|
|
US7014862B2
(en)
|
2002-05-20 |
2006-03-21 |
The Procter & Gamble Company |
Chewable compositions containing a gel-forming extract of psyllium
|
|
US6923466B2
(en)
|
2002-12-17 |
2005-08-02 |
James Tsai |
Collapsible handcart capable of extending the area of carrier by operating handle
|
|
US7304036B2
(en)
|
2003-01-28 |
2007-12-04 |
Microbia, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
US20050054705A1
(en)
|
2003-02-04 |
2005-03-10 |
Aventis Pharma Deutschland Gmbh |
N-substituted (benzoimidazol-2-yl) phenylamines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
|
|
US7026303B2
(en)
|
2003-02-18 |
2006-04-11 |
The Procter & Gamble Company |
Compositions comprising a polysaccharide component and one or more coating layers
|
|
WO2004085448A2
(en)
|
2003-03-19 |
2004-10-07 |
Genzyme Corporation |
Unsaturated phosphinyl-phosphonate phosphate transport inhibitors
|
|
DE10312963A1
(de)
|
2003-03-24 |
2004-10-07 |
Aventis Pharma Deutschland Gmbh |
Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
|
|
US7241775B2
(en)
|
2003-03-24 |
2007-07-10 |
Sanofi-Aventis Deutschland Gmbh |
Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines
|
|
EP1614676A4
(en)
|
2003-03-27 |
2009-03-25 |
Kirin Pharma Kk |
CONNECTION TO INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICAMENT CONTAINING THEREOF
|
|
US20050244367A1
(en)
|
2004-05-03 |
2005-11-03 |
Ilypsa, Inc. |
Phospholipase inhibitors localized in the gastrointestinal lumen
|
|
AU2005257832A1
(en)
|
2004-05-14 |
2006-01-05 |
The University Of North Carolina At Chapel Hill |
Prouroguanylin as therapeutic and diagnostic agents
|
|
DE102004046492A1
(de)
|
2004-09-23 |
2006-03-30 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
|
|
DE102004054847A1
(de)
|
2004-11-13 |
2006-05-24 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
|
DE102005001411A1
(de)
|
2005-01-12 |
2006-07-27 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
|
|
DE102005044815A1
(de)
|
2005-09-20 |
2007-03-22 |
Sanofi-Aventis Deutschland Gmbh |
Verwendung von Inhibitoren des Na+/H+ Austauschers, Subtyp 5 (NHE5) zur Gedächtnisverbesserung
|
|
DE102005044817A1
(de)
|
2005-09-20 |
2007-03-22 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
|
|
EP1951315A2
(en)
|
2005-11-03 |
2008-08-06 |
Ilypsa, Inc. |
Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors
|
|
MX2008005666A
(es)
|
2005-11-03 |
2009-03-02 |
Ilypsa Inc |
Compuestos multivalentes de indol y uso de los mismos como inhibidores de fosfolipasa-a2.
|
|
WO2008002971A2
(en)
|
2006-06-29 |
2008-01-03 |
Microbia, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
EP2129683A4
(en)
|
2007-02-26 |
2011-01-05 |
Ironwood Pharmaceuticals Inc |
METHODS AND COMPOSITIONS FOR TREATMENT OF HEART FAILURE AND OTHER DISORDERS
|
|
EP2152266A4
(en)
|
2007-05-04 |
2010-07-28 |
Ironwood Pharmaceuticals Inc |
COMPOSITIONS AND METHODS OF TREATING DISORDERS RELATED TO SALT OR LIQUID RETENTION
|
|
BRPI0918502A2
(pt)
|
2008-09-02 |
2015-12-01 |
Sanofi Aventis |
aminoindanos substituídos e análogos dos mesmos, e o uso farmacêutico dos mesmos
|
|
MX2011007024A
(es)
*
|
2008-12-31 |
2011-09-27 |
Aedelyx Inc |
Compuestos y metodos para inhibir el antiporte mediado por intercambiador de iones de sodio/iones de hidrogeno (nhe) en el tratamiento de trastornos asociados con retencion de fluido o sobrecarga de sal y trastornos del tracto gastrointestinal.
|
|
EP2591354B1
(en)
|
2010-07-07 |
2016-09-07 |
Ardelyx, Inc. |
Compounds and methods for inhibiting phosphate transport
|
|
EP2590656B1
(en)
|
2010-07-07 |
2017-11-15 |
Ardelyx, Inc. |
Compounds and methods for inhibiting phosphate transport
|
|
WO2012006473A1
(en)
|
2010-07-07 |
2012-01-12 |
Ardelyx, Inc. |
Compounds and methods for inhibiting phosphate transport
|
|
EP2590510B1
(en)
*
|
2010-07-07 |
2016-09-28 |
Ardelyx, Inc. |
Compounds and methods for inhibiting phosphate transport
|
|
EP2887963B1
(en)
*
|
2012-08-21 |
2017-07-19 |
Ardelyx, Inc. |
Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
|
|
MX366293B
(es)
|
2012-08-21 |
2019-07-04 |
Ardelyx Inc |
Compuestos y metodos para inhibir al antipuerto mediado por nhe en el tratamiento de trastornos asociados con la retencion de fluidos o la sobrecarga de sal y trastornos del tracto gastrointestinal.
|
|
KR20250026881A
(ko)
*
|
2013-04-12 |
2025-02-25 |
알데릭스, 인코포레이티드 |
Nhe3-결합 화합물 및 포스페이트 수송을 저해하는 방법
|